The CDMO Division of Lubrizol Life Science Health (LLS Health) is a leading pharmaceutical contract development and drug product manufacturing organization (CDMO). Staffed by industry experts, we offer R&D formulation and clinical/commercial drug product manufacturing supported by analytical testing, ICH stability programs, and HPAPI/controlled substance handling. Our technology-agnostic team welcomes your formulation and production challenges with expertise in solubility/bioavailability enhancement, sterile/aseptic manufacturing, and long-acting injectables/implantables.